Active PKG II inhibited the growth and migration of ovarian cancer cells through blocking Raf/MEK and PI3K/Akt signaling pathways
Yan Wu(Zhejiang Chinese Medical University), Yongchang Chen(Jiangsu University), Ji Pang(Jiangsu University), Wei Li(Harbin Medical University), Zhensheng Cai(Jiangsu University), Cai Qin(Jiangsu University), Ying Liu(Guiyang Medical University), Hongfan Li(Chinese National Human Genome Center)
Cited by 16
Related Papers
PARP inhibitor resistance: the underlying mechanisms and clinical implications
|Molecular Cancer|2020|548
Epidemiology of Carbapenem-Resistant Enterobacteriaceae Infections: Report from the China CRE Network
|Antimicrobial Agents and Chemotherapy|2017|472
Mesenchymal stem cells derived from bone marrow favor tumor cell growth in vivo
|Experimental and Molecular Pathology|2005|388
Mesenchymal Stern Cells from Adult Human Bone Marrow Differentiate into a Cardiomyocyte Phenotype In Vitro
|Experimental Biology and Medicine|2004|372